Form 4: Alphatec Holdings Executive Sells Shares Under 10b5-1 Plan

An Alphatec Holdings executive sold 62,018 shares of common stock at an average price of $9.69, according to a recent SEC filing.

Summary

• David Sponsel, an Executive Vice President at Alphatec Holdings, sold 62,018 shares of common stock on December 11, 2024.
• The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 11, 2024.
• The shares were sold at a weighted average price of $9.69, with individual transaction prices ranging from $9.51 to $9.79.
• Following the transaction, Sponsel beneficially owns 560,832 shares of Alphatec common stock.
• This total includes 216 shares acquired on May 15, 2024 and 338 shares acquired on November 15, 2024 through the company's employee stock purchase plan.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction under a pre-arranged trading plan, which is neither particularly positive nor negative.

Risks

• Executive stock sales can sometimes be perceived negatively by the market, potentially impacting investor sentiment.

Industry Context

Executive stock sales are a common occurrence, and this transaction is not unusual for a company of Alphatec's size and stage. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• Executive stock sales are a common practice across the industry, with many executives using 10b5-1 plans to manage their holdings.
• Companies like Medtronic, Stryker, and Johnson & Johnson also see similar filings from their executives.
• The volume of shares sold is not unusual for an executive at this level, and the price range is within normal market fluctuations.

Stakeholder Impact

• The sale may have a minor impact on shareholder sentiment, but it is unlikely to cause significant concern given the pre-planned nature of the transaction.

Key Dates

Keywords

Alphatec Holdings, stock sale, insider trading, SEC Form 4, Rule 10b5-1, executive, ATEC